← Lobby register
Disclosed budget
€715,000
Meetings 12mo
0
Policy files
0
Accredited passes
1
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 06 Mar 2023 | Roberto Reig Rodrigo Cabinet member | VTC Meeting: New Genomic Techniques (NGTs) | — |
| 06 Mar 2023 | Roberto Reig Rodrigo Cabinet member | VTC Meeting: New Genomic Techniques (NGTs) | SRC |
| 24 Oct 2022 | Joanna Stawowy Cabinet member | New genetic engineering techniques (NGTs) | — |
| 24 Oct 2022 | Joanna Stawowy Cabinet member | New genetic engineering techniques (NGTs) | SRC |
| 20 Oct 2022 | Maciej Golubiewski Cabinet member | Potential and risks of new genetic engineering techniques (NGTs) | — |
| 20 Oct 2022 | Maciej Golubiewski Cabinet member | Potential and risks of new genetic engineering techniques (NGTs) | SRC |
| 08 Apr 2022 | Joanna Stawowy Cabinet member | New Genomic Techniques | — |
| 08 Apr 2022 | Joanna Stawowy Cabinet member | New Genomic Techniques | SRC |
| 15 Sept 2021 | Roberto Reig Rodrigo Cabinet member | VTC meeting on New Genomic Techniques | SRC |
| 15 Sept 2021 | Roberto Reig Rodrigo Cabinet member | VTC meeting on New Genomic Techniques | — |
| 15 Sept 2021 | Lukas Visek Cabinet member | New genomic techniques | — |
| 15 Sept 2021 | Lukas Visek Cabinet member | New genomic techniques | SRC |
| 24 Feb 2021 | Lukas Visek Cabinet member | New genomic techniques | SRC |
| 24 Feb 2021 | Lukas Visek Cabinet member | New genomic techniques | — |
| 20 Jan 2021 | Agne Razmislaviciute-Palioniene Cabinet member | To discuss new genomic techniques (NGTs) and their impacts | — |
| 20 Jan 2021 | Camilla Bursi Cabinet member | To discuss new genomic techniques (NGTs) and their impacts | SRC |
| 20 Jan 2021 | Agne Razmislaviciute-Palioniene Cabinet member | To discuss new genomic techniques (NGTs) and their impacts | SRC |
| 28 Sept 2015 | Vytenis Andriukaitis Commissioner | New breeding techniques, GMO | SRC |
| 28 Sept 2015 | Vytenis Andriukaitis Commissioner | New breeding techniques, GMO | — |
Mission & Goals
Von der Biotech-Industrie unabhängige Folgenabschätzung im Bereich Biotechnologie. Impact assessment in the area of biotechnology. We are science based and independent from the biotech industry.
EU Legislative Interests
GMO Regulation Regulation of genome editing / new genomic techniques EFSA GMO Panel and approval processes
Communication Activities
siehe www.testbiotech.org
Interests Represented
Does not represent commercial interests
Member Of
European Environmental Bureau, EEB
Additional Information
There are additional smaller funders - see also information on our website